In MS, a curcumin nano formulation improved EDSS score, reduced inflammatory mediators, miRNAs, IFN-γ, CCL2, and CCL5, and increased Sox2, Sirtuin-1, Foxp3, PDCD1 (397). Here, SOX2 is linked to myeloid sarcoma.